₹ 600.70
3.50 (0.59%)
C
Concord Biotech
₹ 600.70
Concord Biotech EPS Summary (consolidated)
The latest quarterly EPS of Concord Biotech as of Q2 Sep 2026 stands at ₹6.65. This is a 20.47% growth quarter on quarter and 10.28% growth same quarter last year. For the FY2026 the EPS of Concord Biotech stands at ₹24.78. This is a 30.24% fall compared with FY2025.
Concord Biotech EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

